News

Sistemic Ltd. and Cynata Therapeutics Limited (ASX:CYP) announced today that they have entered into an agreement which will see Sistemic use its novel SistemQC™ miRNA technology platforms, together with its...

Read More

Cynata Therapeutics Limited CYP-AU: Price: A$0.30; Market Cap (MM): A$22 Rating: Buy; Price Target: A$1.00 Raghuram Selvaraju, Ph.D., Senior Biotechnology Analyst MHRA Favorable Advice Received; Proceeding to Clinical Testing Click here for complete report and disclosures Regulatory...

Read More